BEAMSTART Logo

HomeNews

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore

Times of India LogoTimes of India6h ago

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - Times of India

Quick Summary:

Sun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million.

This strategic acquisition will enhance Sun Pharma's specialty portfolio, including UNLOXCYT, an FDA-approved treatment for advanced skin cancer, expanding its global presence in oncology treatments.

RJ MahvashHolika Dahan 2025Nilu KohliPanipat WeddingHoli 2025Baba Vanga PredictionX DownAthiya ShettyKarnataka WeatherOkra Water BenefitsVivek OberoiVirat KohliOptical illusionHoli Muhurat TimingsHoli WishesMagnesium Oil BenefitsChia Seeds BenefitsBlocked Heart ArteriesMark CarneyMandar ChandwadkarChhaava Box Office CollectionAvocado vs.Not with Beau Barack!


More Pictures

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - Times of India (Picture 1)

or

Article Details

Author / Journalist: TNN

Category: EconomyBusiness

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-03-11 @ 03:17:52 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: timesofindia.indiatimes.com

Language: English

Article Length: 550 words

Reading Time: 4 minutes read

Sentences: 15 lines

Sentence Length: 37 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Times of India

News ID: 26859166

View Article Analysis

About Times of India

Times of India Logo

Main Topics: EconomyBusiness

Official Website: timesofindia.indiatimes.com

Update Frequency: 26 posts per day

Year Established: 1838

Headquarters: India

News Last Updated: 58 minutes ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Local / Regional

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #28

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Sun Pharma to acquire US oncology compony for over Rs 3,000 crore" has 550 words across 15 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Which news outlet covered this story?

The story "Sun Pharma to acquire US oncology compony for over Rs 3,000 crore" was covered 6 hours ago by Times of India, a news publisher based in India.

How trustworthy is 'Times of India' news outlet?

Times of India is a fully independent (privately-owned) news outlet established in 1838 that covers mostly economy and business news.

The outlet is headquartered in India and publishes an average of 26 news stories per day.

It's most recent story was published 58 minutes ago.

What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #26859166
  • URL: https://beamstart.com/news/sun-pharma-to-acquire-us-17416347077642

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.